Biohaven VP exercises 2,500 RSUs; 1,117 shares withheld

Biohaven Vice President and Chief Accounting Officer George C. Clark reported the vesting and conversion of 2,500 restricted share units into common shares on January 5, 2026.

Rhea-AI Filing Summary

Biohaven Vice President and Chief Accounting Officer George C. Clark reported the vesting and conversion of 2,500 restricted share units into common shares on January 5, 2026. To satisfy taxes, 1,117 shares were withheld by the issuer at $9.93 per share rather than sold in the market. After these transactions, he owns 66,978 common shares directly and 20,000 common shares indirectly through an IRA. The RSUs are part of a 10,000-unit grant from January 5, 2025 that vests in four equal annual installments.

Insider Trade Summary

2,500 shares exercised/converted

Exercise 4 txns

Insider Clark George C.

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Share Unit Award	2,500	$0.00	$0.00
Exercise	Common Shares	2,500	$0.00	$0.00
Exercise Price or Tax Liability	Common Shares	1,117	$9.93	$11K
holding	Common Shares	--	--	--

Holdings After Transaction: Restricted Share Unit Award — 5,000 contracts (Direct); Common Shares — 66,978 shares (Direct); Common Shares — 20,000 shares (Indirect, By IRA)

Footnotes (4)

1. F1. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
2. F2. Each restricted share unit represents the contingent right to receive one common share of the Issuer.
3. F3. The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.
4. F4. Not applicable.

Key Figures

RSUs converted to common shares: 2,500 shares Shares withheld for taxes: 1,117 shares Tax withholding price: $9.93 per share +3 more

6 metrics

RSUs converted to common shares 2,500 shares Restricted share units vested and converted on January 5, 2026

Shares withheld for taxes 1,117 shares Common shares withheld by issuer to satisfy tax withholding requirements

Tax withholding price $9.93 per share Per-share value used for shares withheld on January 5, 2026

Direct common share holdings 66,978 shares Common shares held directly after the reported transactions

Indirect IRA holdings 20,000 shares Common shares held indirectly through an IRA after the transactions

RSU grant size 10,000 units Restricted share units granted on January 5, 2025, vesting in four installments

Key Terms

Restricted share unit, tax withholding requirements, contingent right

3 terms

Restricted share unit financial

"The reporting person was granted 10,000 restricted share units on January 5, 2025"

A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.

tax withholding requirements financial

"shares were withheld by the Issuer to satisfy tax withholding requirements"

contingent right financial

"Each restricted share unit represents the contingent right to receive one common share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Biohaven (BHVN) report for George C. Clark?

George C. Clark reported that 2,500 restricted share units vested and converted into common shares on January 5, 2026. To cover taxes, 1,117 shares from this vesting were withheld by the issuer at $9.93 per share, with no open-market sales.

How many Biohaven (BHVN) shares does George C. Clark hold after these transactions?

After the reported transactions, George C. Clark holds 66,978 common shares directly. In addition, he has an indirect position of 20,000 common shares held through an IRA, reflecting both his direct ownership and retirement-related holdings in Biohaven.

How were taxes handled on George C. Clark’s Biohaven (BHVN) RSU vesting?

Taxes were satisfied by withholding 1,117 common shares at $9.93 per share in connection with the RSU vesting. The issuer retained these shares to meet tax obligations, and the disclosure states that no shares were actually sold in the market.

What are the terms of George C. Clark’s 10,000 Biohaven (BHVN) RSU grant?

Clark received a grant of 10,000 restricted share units on January 5, 2025. The grant vests in four equal installments on January 5 of 2025, 2026, 2027 and 2028, subject to his continued service with Biohaven at each vesting date.

Were any Biohaven (BHVN) shares sold in the market in this Form 4?

No market sales were reported; 1,117 shares were withheld by the issuer to satisfy tax withholding requirements related to RSU vesting. The disclosure explicitly notes that these withheld shares were not sold, but retained to cover tax liabilities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 09:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clark George C.

(Last) (First) (Middle)

C/O BIOHAVEN LTD.

215 CHURCH STREET

(Street)

NEW HAVEN CT 06510

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Biohaven Ltd. [ BHVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/05/2026		M		2,500	A	$0	68,095	D
Common Shares	01/05/2026		F		1,117(1)	D	$9.93	66,978	D
Common Shares								20,000	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit Award	(2)	01/05/2026		M			2,500	(3)	(4)	Common Shares	2,500	$0(2)	5,000	D

Explanation of Responses:

1. No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.

2. Each restricted share unit represents the contingent right to receive one common share of the Issuer.

3. The reporting person was granted 10,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date.

4. Not applicable.

Remarks:

	/s/ George Clark	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.